Skip to main content

Table 3 Relative odds of PAD according to VAI in different models among normal-weight hypertensive patients in different sex

From: Visceral adiposity index and sex differences in relation to peripheral artery disease in normal-weight adults with hypertension

VAI Index

Participants, n

Cases, n

PAD, OR (95%CI)

Model 1

Model 2

Model 3

Model4

Male

      

 Per 1 unit increase

3195

127 (3.97%)

1.65 (1.26, 2.17)

1.94 (1.46, 2.59)

1.96 (1.38, 2.79)

2.12 (1.46, 3.07)

Quartiles

      

 Q1 (< 0.64)

799

18 (2.25%)

Reference

Reference

Reference

Reference

 Q2 (1.17 to < 1.76)

798

37 (4.64%)

1.98 (1.11, 3.54)

2.20 (1.22, 3.94)

1.89 (0.95, 3.76)

1.94 (0.97, 3.90)

 Q3 (1.76 to < 2.74)

799

37 (4.63%)

2.18 (1.22, 3.89)

2.56 (1.41, 4.62)

2.32 (1.16, 4.63)

2.27 (1.13, 4.60)

 Q4 (≥ 2.74)

799

35 (4.38%)

2.83 (1.57, 5.09)

3.67 (1.99, 6.77)

3.11 (1.49, 6.49)

3.26 (1.53, 6.93)

Female

      

 Per 1 unit increase

3420

85 (2.49%)

1.34 (0.96, 1.86)

1.44 (1.03, 2.03)

1.24 (0.83, 1.86)

1.28 (0.85, 1.95)

Quartiles

      

 Q1 (< 1.17)

855

14 (1.64%)

Reference

Reference

Reference

Reference

 Q2 (1.17 to < 1.76)

855

23 (2.69%)

1.62 (0.82, 3.20)

1.70 (0.86, 3.36)

1.20 (0.54, 2.68)

1.23 (0.54, 2.75)

 Q3 (1.76 to < 2.74)

855

23 (2.69%)

1.80 (0.91, 3.54)

1.85 (0.93, 3.66)

1.86 (0.86, 4.02)

1.89 (0.86, 4.13)

 Q4 (≥ 2.74)

855

25 (2.92%)

2.14 (1.09, 4.17)

2.39 (1.21, 4.71)

1.77 (0.80, 3.92)

1.82 (0.81, 4.07)

  1. Model 1 was adjusted for age
  2. Model 2 was adjusted for age, BMI, SBP, DBP
  3. Model 3 was adjusted for age, BMI, SBP, DBP, diabetes mellitus, stroke, CHD, antihypertensive drugs, lipoprotein-lowering drugs, glucose-lowering drugs, current smoking, current drinking, education, physical activity
  4. Model 4 was adjusted for age, BMI, SBP, DBP, diabetes mellitus, stroke, CHD, antihypertensive drugs, lipoprotein-lowering drugs, glucose-lowering drugs, current smoking, current drinking, education, physical activity, Hcy, FBG, TC, LDL, eGFR, serum aspartate aminotransferase, serum alanine aminotransferase, serum γ-glutamyltransferase